Scientists from the Berlin Institute of Health at Charité (BIH), together with colleagues from Charité – Universitätsmedizin Berlin and the university hospitals in Bonn and Aachen, have found a type of immune cells that is particularly active in severely ill COVID-19 patients. The CD16 positive T…
The clinical phase II trial CATCOVID initiated by the Berlin Institute of Health at Charité (BIH) has cleared the final regulatory hurdles with the receipt of a positive ethics committee vote and with approval from the Federal Institute for Drugs and Medical Devices (BfArM), enrolling its first…
Scientists at the Berlin Institute of Health at Charité (BIH) and Charité – Universitätsmedizin Berlin have developed an automatable method for the histological examination of three-dimensional tissue preparations. Their idea could revolutionize microscopic tissue examinations and ease the burden on…
Dr. Kirsten Kübler, a faculty member at Harvard Medical School, has been awarded the Johanna Quandt Professorship for Early Cancer Development and Prevention at the Berlin Institute of Health at Charité (BIH). The specialist in gynecology has so far been working at the Massachusetts General Hospital…
The International Health-Tech Pilot Program promotes forward-looking healthcare solutions from Israel. Now, the first collaboration agreements between Israeli start-up companies, Charité-Universitätsmedizin Berlin, the Berlin Institute of Health at Charité (BIH) and the Israel Innovation Authority…
The Einstein Foundation Berlin has presented the inaugural Einstein Foundation Berlin Award for Promoting Quality in Research on November 24, 2021. A prestigious, interdisciplinary jury selected the American physicist Paul Ginsparg, founder of the open source preprint server arXiv.org, and the…
In a study undertaken in more than 10,000 individuals, and published today in Nature Communications, scientists have shown that integrating information derived from different technologies to measure proteins can identify otherwise hidden links between proteins and human health and disease. The…
Scientists from the Berlin Institute of Health at Charité (BIH) and the MDC, together with colleagues from Heidelberg Institute of Stem Cell Research and Experimental Medicine (HI-STEM) at the German Cancer Research Center (DKFZ) and more researchers from Heidelberg and Barcelona, have traced the…
Jeanette Erdmann of the Universität zu Lübeck and Ralph Knöll of Karolinska Institutet and Astra Zeneca in Stockholm are the recipients of this year’s BIH Excellence Award for Sex and Gender Aspects in Health Research of the Berlin Institute of Health at Charité (BIH). Together with their project…
The prognosis for pancreatic cancer is usually grim: The tumors are often detected too late and are then difficult to treat. Yet a small percentage of patients survive many years after diagnosis. Scientists from the Berlin Institute of Health at Charité (BIH) have now grown organoids from various…
The SARS-CoV-2 coronavirus has had us in its grip for almost two years. Scientists have accomplished a great deal during this time: They have decoded the virus’s genome, developed tests and vaccines, and investigated how the virus takes hold in the body and spreads from person to person. Yet despite…
Professor Birgit Sawitzki has accepted a lifetime W3 Professorship in Translational Immunology at the Berlin Institute of Health at Charité (BIH). The trained biochemist investigates how immune cells interact in severe inflammatory responses. These occur in severe courses of COVID-19, in autoimmune…
Although all the world has been focusing on vaccinations, infection rates and ICU occupancy levels, BIH scientists believe the real big wave is still coming: Long COVID. The patients who successfully survived COVID-19 but are still suffering from long-term effects will in all likelihood continue to…
On Tuesday, October 19, Berlin’s Governing Mayor Michael Müller officially opened the exhibition “Berlin – Hauptstadt der Wissenschaftlerinnen” in the great banqueting hall of the Rotes Rathaus, or Red City Hall. Twenty exhibition panels describe the life and career of selected women scientists and…
Hundreds of connections between different human diseases have been uncovered through their shared origin in our genome by an international research team led by scientists at the Berlin Institute of Health at Charité (BIH) and the University of Cambridge, challenging the categorisation of diseases by…
Professor Sylvia Thun is a physician, engineer, and expert in IT healthcare standards. The Director of the Core Unit eHealth and Interoperability at the Berlin Institute of Health at Charité (BIH) has now been awarded a lifetime W3 Professorship in Digital Medicine and Interoperability. Her aim is…
Dr. Dieter Beule has been appointed to a lifetime W2 Professorship in Translational Bioinformatics at the Berlin Institute of Health at Charité (BIH). His aim is to make complex molecular data from technologies and techniques like genome sequencing, single-cell analysis and proteome quantification…
Young adults aged 18 to 24 are at the highest risk of becoming overweight or developing obesity in the next decade of their life compared to adults in any other age group, and obesity prevention policies should target this group, according to a new study led by researchers at the Berlin Institute of…
On June 24, 2021, the BIH Governing Board confirmed Dr. Michael Frieser as the new Administrative Director of the Berlin Institute of Health at Charité (BIH). He succeeds Andrea Runow, who has held the post since January 1, 2019, and is now retiring. Dr. Michael Frieser, 55, who currently heads the…
Dr. Kathrin de la Rosa has been awarded the Johanna Quandt Professorship for Translational Immune Mechanisms at the Berlin Institute of Health at Charité (BIH). De la Rosa is a trained biologist interested in the immune system in general and antibodies, B cells and vaccines in particular. One of her…
Professor Sarah Hedtrich has been awarded the Johanna Quandt Professorship for Translational Human Organ Models at the Berlin Institute of Health at Charité (BIH). Hedtrich, who holds a PhD in pharmacology, is particularly interested in rare hereditary and inflammatory diseases of the skin and lung.…
Children can also be infected with the novel coronavirus SARS-CoV-2, but have a substantially lower risk for developing severe COVID-19 disease compared to adults. A team of scientists from the Berlin Institute of Health at Charité (BIH), Charité – Universitätsmedizin Berlin, University of Leipzig…
The project Hauptstadt der Wissenschaftlerinnen, or Capital of Women in Science – backed by the Berlin Institute of Health at Charité (BIH) and the Berlin Senate Chancellery – wants to raise the visibility of Berlin’s female scientists through Wikipedia articles. Three workshops will give interested…
EBRAINS is a digital research infrastructure, created by the EU-funded Human Brain Project, that aims to digitally explore and decode the human brain. Now, after a highly competitive selection process, EBRAINS has been included in the 2021 Roadmap of the European Strategy Forum on Research…
Dr. Janine Altmüller’s goal is to raise the profile of genomics research in Berlin. Since July 1 she has headed the BIH and MDC’s joint Genomics Platform, providing support to Berlin researchers and honing new methods and technologies. Unlike genetics, which is the study of single genes, genomics…
Dr. Anton Henssen, a scientist and physician at the ECRC, has received the Young Investigator Award of the 2020 Berliner Wissenschaftspreis for his cutting-edge research into childhood cancers. Henssen has been a member of the BIH Charité (Junior) Clinician Scientist Program since 2017. The award of…
Back in March 2020, Charité joined forces with the Potsdam-based nonprofit organization Data4Life to develop CovApp, which allows users to fill out a questionnaire, determine their personal risk of being infected with the SARS-CoV-2 coronavirus, and receive recommendations for the next steps to…
Lower back pain is one of the most common ailments of the musculoskeletal system. It therefore has great medical, social and not least economic implications. The interdisciplinary Research Unit “The Dynamics of the Spine: Mechanics, Morphology and Motion towards a Comprehensive Diagnosis of Low Back…
x-cardiac GmbH has been certified as a medical device manufacturer in the EU while at the same time receiving market authorization for its first medical device x-c-bleeding. The AI-based software can quickly predict the risk of postoperative bleeding in patients. Specialists at the German Heart…
Scientists from the BIH at Charité and the MDC have teamed up with U.S. and Japanese researchers to take single-cell analysis to a new level. They combined methods for determining mRNA levels and DNA accessibility with those used for detecting proteins and mutations in mitochondrial DNA, thus…
